Epidemiology & Risk Factors

  • High prevalence in reproductive-age females.
  • Functional Cysts: Most common overall; related to ovulation. c
    • Follicular cyst: Failure of follicle rupture during ovulation.
    • Corpus luteum cyst: Failure of corpus luteum involution post-ovulation.
  • Benign Neoplasms:
    • Mature Cystic Teratoma (Dermoid cyst): Most common benign ovarian mass in young females (15–30 y/o).
    • Endometrioma: “Chocolate cyst” secondary to endometriosis.
    • Serous/Mucinous Cystadenoma: Benign epithelial tumors.
  • Risk Factors for Malignancy: Postmenopausal status, BRCA1/BRCA2 mutations, Lynch syndrome, nulliparity, early menarche/late menopause.
  • Protective Factors: OCPs (suppress ovulation), multiparity, prolonged breastfeeding.

Clinical Features

  • Uncomplicated/Simple Cysts: Mostly asymptomatic; found incidentally on pelvic exam or imaging.
  • Symptomatic Cysts:
    • Unilateral lower quadrant/pelvic pain (dull, aching).
    • Pelvic pressure, fullness, or bloating.
    • Dyspareunia or dysmenorrhea (suggestive of endometrioma).
  • Acute Severe Pain: Indicates cyst rupture or ovarian torsion.
  • Physical Exam: Unilateral adnexal tenderness or palpable mobile mass.
    • Fixed, nodular mass w/ ascites suggests malignancy.

Diagnosis

  • Initial & Best Test: Pelvic Ultrasound (Transvaginal US [TVUS] preferred).
    • Simple Cyst: Thin-walled, anechoic, unilocular, smooth margins, no solid components/septa.
    • Dermoid Cyst (Teratoma): Hyperechoic mass w/ acoustic shadowing (hair, calcifications/teeth).
    • Endometrioma: Homogeneous low-level internal echoes (“ground-glass” appearance).
    • Malignant Features: Solid components, thick septations, internal flow on Doppler, loculated/multilocular, associated ascites, size >10 cm.
  • Key Labs:
    • β-hCG: Rule out ectopic pregnancy or gestational trophoblastic disease.
    • CA-125: Biomarker elevated in epithelial ovarian cancers. Best diagnostic/prognostic utility in postmenopausal women (low specificity in premenopausal females due to elevation in endometriosis, fibroids, PID).
    • CBC: Check for leukocytosis (infection/TOA) or anemia (hemoperitoneum from ruptured cyst).

Differential Diagnostics

  • Ectopic Pregnancy: Differentiated by (+) β-hCG, amenorrhea, vaginal bleeding, empty uterus on TVUS.
  • Ovarian Torsion: Differentiated by sudden onset severe unilateral pain w/ N/V and decreased/absent Doppler flow on TVUS.
  • Tubo-Ovarian Abscess (TOA): Differentiated by complex multilocular adnexal mass w/ fever, purulent cervical discharge, and cervical motion tenderness.
  • Polycystic Ovary Syndrome (PCOS): Differentiated by bilateral “string of pearls” appearance on US, hyperandrogenism, oligomenorrhea, and obesity.
  • Appendicitis: Differentiated by RLQ pain, migration from periumbilical region, fever, (+) McBurney point tenderness.

Management

  • Premenopausal Females:
    • Simple Cyst <10 cm & Asymptomatic: Observation & Reassurance. Repeat TVUS in 4–12 weeks (most resolve spontaneously within 1–2 menstrual cycles).
    • Simple/Complex Cyst >10 cm OR Persistent OR Symptomatic: Surgical evaluation via Laparoscopic Cystectomy (preserves fertility).
  • Postmenopausal Females:
    • Simple Cyst <5 cm w/ Normal CA-125: Serial TVUS and serum CA-125 monitoring every 3–6 months.
    • Complex Cyst / Mass >5–10 cm / Elevated CA-125: Urgent Gynecologic Oncology consult for exploratory laparotomy and intraoperative staging.
  • Ruptured Ovarian Cyst:
    • Hemodynamically Stable (Uncomplicated): Observation, oral analgesics, outpatient rest.
    • Hemodynamically Unstable (Complicated / Active Hemorrhage): Emergency Laparoscopy for hemostasis.

Complications

  • Ovarian Torsion: Occlusion of ovarian blood supply leading to ischemic necrosis (surgical emergency).
  • Cyst Rupture & Hemoperitoneum: Can lead to significant internal bleeding and hypovolemic shock.
  • Malignant Transformation: Risk significantly increased in postmenopausal complex masses.